Physician profile
James Goszkowski
NPI 1770571739
$1,235.82
in general payments reported to CMS, 2019-2025
10 companies · $53.33 in 2025
The $53.33 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $98.55 · 2021: $128 · 2022: $275 · 2023: $256 · 2025: $53.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $275.70 | 2021-2023 | Arexvy |
| Lilly USA, LLC | $238.09 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $212.45 | 2019-2023 | |
| Boston Scientific Corporation | $159.99 | 2019-2021 | |
| Painteq LLC | $146.87 | 2021-2023 | Painteq |
| Sanofi-Aventis U.S. LLC | $103.05 | 2019 | |
| Xeris Pharmaceuticals, INC. | $32.35 | 2025 | Keveyis |
| Novo Nordisk INC | $32.27 | 2019 | |
| Exact Sciences Corporation | $20.98 | 2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $14.07 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Goszkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.